Inhibikase Therapeutics (IKT) - Bozor kapitallashuvining balans qiymatiga nisbati
Inhibikase Therapeutics (IKT) kompaniyasining ushbu narx evolyutsiyasi grafigi Parkinson kasalligi uchun terapiya vositalarini ishlab chiqayotgan kompaniyaning dinamikasini namoyish etadi. Biznes noyob patentlar va murakkab ishlanmalarga tayanadi, ular FDA ning qat'iy nazorati bilan birgalikda yangi ishtirokchilar uchun kirishning yuqori to'siqlarini yaratadi. Jamoa ilmiy yutuqlar uchun zarur resurslarga ega bo'lgan yetakchi olimlardan tashkil topgan. Joriy ko'rsatkich 1.33 darajasida turibdi, kelgusidagi potentsial foydalar esa dori vositalarining samaradorligiga bog'liq bo'ladi.
%20Bozor%20qiymatining%20balans%20qiymatiga%20koeffitsiyenti&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_IKT_-_Inhibikase-Therapeutics_-_Market-to-Book-Ratio "Inhibikase (IKT): Kapitallashuvning sof aktivlarga nisbati 04.07.2022dan 31.10.2026gacha | 👁️GURU.Markets👁️")
Inhibikase Therapeutics kompaniyasining tahliliy kesimlari
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Inhibikase Therapeutics|IKT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Inhibikase|IKT - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Inhibikase|IKT - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzlari Inhibikase Therapeutics|Tezkor likvidlik koeffitsiyenti inhibikase.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
Kompaniyaning barcha koʻrsatkichlari tahlili:Inhibikase Therapeutics
Bozor qiymati va kapitalning qiyosiy tahlili investorga aktivlarning haqiqiy balans qiymatiga nisbatan spekulyativ haddan tashqari baholanganlik darajasini aniqlash imkonini beradi. Parkinson kasalligiga yo'naltirilgan yuqori xavfli yagona mahsulotli platformaga e'tibor qaratgan Inhibikase Therapeutics (IKT) uchun bozor qiymatining balans qiymatiga nisbatining dinamikasi, klinik sinovlar muvaffaqiyatsiz tugashi holatida kapitalning muzlatilishiga olib kelishi mumkin bo'lgan shishirilgan kutishlarning ko'rsatkichi bo'lib xizmat qiladi.
Muhim raqobatchilar
Biogen Inc. (BIIB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati NBIX|RGC (Regencell Bioscience Holdings Limited) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Axsome AXSM|Kapitallashuvning sof aktivlarga nisbati ACAD (ACADIA Pharmaceuticals Inc)|Bozor kapitallashuvining balans qiymatiga nisbati Xenon Corp (XENE)|Bozor qiymatining balans qiymatiga nisbati Viking Therapeutics VKTX|Balans qiymatiga nisbatan bozor qiymati SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Denali|HRMY: Bozor kapitallashuvining balans qiymatiga nisbati|BHVN - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals|Kapitallashuvning balans qiymatiga nisbati TRVI (trevitherapeutics.com)|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|AVXL (Anavex) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CBLL (CeriBell Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Prothena (PRTA)|Alector Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX: Bozor qiymatining balans qiymatiga nisbati|OMER: Bozor kapitallashuvining balans qiymatiga nisbati|NGNE - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AC Immune Corp|Bozor kapitallashuvining balans qiymatiga nisbati Voyager Corp|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|Bozor kapitallashuvining balans qiymatiga nisbati scilexholding.com (SCLX)|Bozor qiymatining balans qiymatiga nisbati Tevogen Bio TVGN|Balans qiymatiga nisbatan bozor kapitallashuvi Alpha Cognition Inc (ACOG)|Cognition Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cassava Pharma|ASRT (assertiotx.com) - Kapitallashuvning sof aktivlarga nisbati|Coya Therapeutics - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati VTGN|OVID (Ovid Rx) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|CRVO (CervoMed Corporation) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ATHE (Alterity Therapeutics Limited)|Clene Inc (CLNN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|PEPG - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati JUNS (jupiterneurosciences.com)|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|Annovis Bio Corporation (ANVS) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Grace Therapeutics Inc|fireflyneuro.com - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati KLTO|NRSN - Bozor qiymatining balans qiymatiga koeffitsiyenti|Reviva Pharmaceuticals Holdings - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MetaVia Inc. MTVA|NRXS: Kapitallashuvning sof aktivlarga nisbati|Helius Medical - Bozor kapitallashuvining balans qiymatiga multiplikatori|PASG: Bozor kapitallashuvining balans qiymatiga nisbati|NEUP - Balans qiymatiga nisbatan bozor kapitallashuvi|NERV (Minerva Neurosciences Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Athira Pharma Corp (ATHA)|Bozor qiymatining balans qiymatiga nisbati Addex Therapeutics (ADXN)|Balans qiymatiga nisbatan bozor kapitallashuvi alzamend.com|Bozor kapitallashuvining balans qiymatiga nisbati CYCN (Cyclerion Therapeutics, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi Protagenic Therapeutics Inc. (PTIX)|KTTA - Bozor qiymatining balans qiymatiga nisbati|CRGT - Bozor kapitallashuvining balans qiymatiga nisbati|ATXI (Avenue Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|BCLI: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics|Kapitallashuvning balans qiymatiga nisbati CHRO (Chromocell Therapeutics Corp)|Bozor kapitallashuvining balans qiymatiga nisbati ELYM|ITCI - Bozor qiymatining balans qiymatiga koeffitsiyenti|Longboard Pharmaceuticals - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati marinuspharma.com MRNS|NKGN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc (SNPX)|TRVN (Trevena, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Vigil Neuro (VIGL) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. (WENA)|Cerevel Therapeutics Inc - Kapitallashuvning balans qiymatiga nisbati